Home Big Pharma: Dealing With Fewer Biotech Targets
 

Keywords :   


Big Pharma: Dealing With Fewer Biotech Targets

2016-01-01 00:50:16| Biotech - Topix.net

There have been 2,000-plus deals over the past two years in pharma and biotech, but the pace isn't likely sustainable The torrid pace of consolidation among drugmakers is bound to slow at some point. But that doesn't mean deal bankers and lawyers will be idle in 2016.

Tags: big dealing fewer targets

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.06Mining for Pearlizing Agent 
01.06The Power of Zinc Pyrithione
01.06Downward pH Drift
01.06Adding Fragrances to Hot Pours
01.06The Perils of Progress in the Search for New UV Filters
01.06This Interview Formality Jumpstarts Or Kills Your Chances Altogether
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
More »